RESUMEN
For Pacific salmon captured and released by fisheries, post-release behaviour and survival may be influenced by their health and condition at time of capture. We sought to characterize the interactions between infectious agent burden, fish immune and stress physiology and fisheries stressors to investigate the potential for capture-mediated pathogen-induced mortality in adult coho salmon Oncorhynchus kisutch. We used radio-telemetry paired with high-throughput qPCR of non-lethal gill biopsies for infectious agents and host biomarkers from 200 tagged fish experimentally displaced and exposed to various experimental fisheries treatments (gill net entanglement, recreational angling and recreational angling with air exposure vs. non-sampled control). We characterized relationships among post-release behaviour and survival, infectious agent presence and loads, physiological parameters and transcription profiles of stress and immune genes. All infectious agents detected were endemic and in loads consistent with previous adult Pacific salmon monitoring. Individuals exposed to fisheries treatments were less likely to reach spawning habitat compared to controls, and handling duration independent of fisheries gear had a negative effect on survival. High infectious agent burden was associated with accelerated migration initiation post-release, revealing behavioural plasticity in response to deteriorating condition in this semelparous species. Prevalence and load of infectious agents increased post-migration as well as transcription signatures reflected changes in immune and stress profiles consistent with senescence. Results from this study further our understanding of factors associated with fisheries that increase risk of post-release mortality and characterize some physiological mechanisms that underpin migratory behaviour.
RESUMEN
Anadromous fishes such as steelhead trout, Oncorhynchus mykiss, are exposed to a suite of infectious agents and migratory challenges during their freshwater migrations. We assessed infectious agent load and richness and immune system gene expression in gill tissue of Bulkley River (British Columbia, CA) steelhead captured at and upstream of a migratory barrier to evaluate whether infectious burdens impacted migration success. We further considered the potential influences of water temperature, sex and fish size on host infectious agents and transcription profiles. There were eight infectious agents detected in steelhead gill tissue, with high prevalence of the bacteria Candidatus Branchiomonas cysticola (80%) and Flavobacterium psychrophilum (95%) and the microparasite Sphaerothecum destruens (53%). Fish sampled at the falls had significantly greater relative loads of Ca. B. cysticola and F. psychrophilum, higher infectious agent richness and differential gene expression compared to fish captured upstream. Flavobacterium psychrophilum was only associated with immune gene expression (particularly humoral immunity) of fish sampled at the falls, while water temperature was positively correlated with genes involved in the complement system, metabolic stress and oxidative stress for fish captured upstream. This work highlights interesting differences in agent-host interactions across fisheries and suggests that hydraulic barriers may reduce the passage of fish with the heaviest infectious agent burdens, emphasizing the selective role of areas of difficult passage. Further, this work expands our knowledge of infectious agent prevalence in wild salmonids and provides insight into the relationships between infectious agents and host physiology.
RESUMEN
Excessive sedimentation derived from anthropogenic activities is a main factor in habitat and biodiversity loss in freshwater ecosystems. To prevent offsite movement of soil particles, many environmental regulatory agencies mandate the use of perimeter silt fences. However, research regarding the efficiency of these devices in applied settings is lacking, and fences are often ineffective due to poor installation and maintenance. Here, we provide an overview of the current state of research regarding silt fences, address the current culture surrounding silt fence installation and maintenance, and provide several recommendations for improving the knowledge base related to silt fence effectiveness. It is clear that there is a need for integrated long-term (i.e., extending from prior to fence installation to well after fence removal) multi-disciplinary research with appropriate controls that evaluates the effectiveness of silt control fences. Through laboratory experiments, in silico modelling and field studies there are many factors that can be experimentally manipulated such as soil types (and sediment feed rate), precipitation regimes (and flow rate), season, slope, level of site disturbance, fence installation method, type of fence material, depth of toe, type and spacing of support structures, time since installation, level of inspection and maintenance, among others, that all require systematic evaluation. Doing so will inform the practice, as well as identify specific technical research needs, related to silt fence design and use. Moreover, what constitutes "proper" installation and maintenance is unclear, especially given regional- and site-level variation in precipitation, slope, and soil characteristics. Educating and empowering construction crews to be proactive in maintenance of silt fencing is needed given an apparent lack of compliance monitoring by regulatory agencies and the realities that the damage is almost instantaneous when silt fences fail. Our goal is not to dismiss silt fences as a potentially useful tool. Instead, we question the way they are currently being used and call for better science to determine what factors (in terms of fence design, installation and site-characteristics) influence effectiveness as well as better training for those that install, maintain and inspect such devices. We also encourage efforts to "look beyond the fence" to consider how silt fences can be combined with other sediment control strategies as part of an integrated sediment control program.
Asunto(s)
Conservación de los Recursos Naturales/métodos , Ecosistema , Biología Marina/métodos , Tecnología/métodos , Biodiversidad , Agua Dulce , Humanos , Biología Marina/educación , Estaciones del Año , Suelo , Tecnología/educaciónRESUMEN
Antiretroviral drug therapy and cytotoxic T lymphocytes (CTL) both exert selective pressures on human immunodeficiency virus type 1, which influence viral evolution. Compared to chronically infected, antiretroviral-untreated patients, most chronically infected, treated patients with detectable viremia lack a cellular immune response against the Gag 77-85(SL9) epitope but show a new immunodominant response against an epitope in protease PR 76-84. Hence, mutations induced by antiretroviral therapy likely alter the profile of epitopes presented to T cells and thus the direction of the response. The consequences of dual pressures from treatment and CTL need to be considered in monitoring of drug therapy.
Asunto(s)
Antirretrovirales/farmacología , Productos del Gen gag/inmunología , Productos del Gen pol/inmunología , VIH-1/inmunología , Inmunidad Celular/efectos de los fármacos , Linfocitos T Citotóxicos/inmunología , VIH-1/genética , Humanos , Epítopos Inmunodominantes , Datos de Secuencia Molecular , Mutación , Selección Genética , Linfocitos T Citotóxicos/efectos de los fármacosRESUMEN
We have previously shown that the selection of haplotype tag single nucleotide polymorphisms (htSNPs) and their statistical analysis in a multi-locus transmission/disequilibrium test (TDT) results in a more cost-effective genotyping strategy in disease association studies of genes by minimising redundancy due to linkage disequilibrium between SNPs. Further savings can be achieved by the use of a two-stage genotyping strategy. This approach is illustrated here in conjunction with the multi-locus TDT in determining whether common alleles of the immune regulatory genes RANK and its ligand TRANCE (RANKL) are associated with type 1 diabetes (T1D). A saving of approximately 75% of potential genotyping reactions could be made with minimal loss of power. There was little evidence from our analysis for association between the TRANCE and RANK genes and T1D in the populations tested.
Asunto(s)
Desequilibrio de Ligamiento , Polimorfismo de Nucleótido Simple , Proteínas Portadoras/genética , Proteínas Portadoras/metabolismo , Diabetes Mellitus Tipo 1/genética , Diabetes Mellitus Tipo 1/metabolismo , Genotipo , Glicoproteínas/genética , Glicoproteínas/metabolismo , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/metabolismo , Osteoprotegerina , Ligando RANK , Receptores Citoplasmáticos y Nucleares/genética , Receptores Citoplasmáticos y Nucleares/metabolismo , Receptores del Factor de Necrosis TumoralRESUMEN
Qualitative and quantitative anomalies of low-density lipoproteins (LDL) play a key role in the pathophysiology of atherosclerosis. Such anomalies are characteristics of the atherogenic dyslipidemias which occur most frequently, i.e. primary hypercholesterolemia of phenotype IIA (including familial hypercholesterolemia), combined hyperlipidemias (Type IIB) and hypertriglyceridemia (Type IV). An elevated concentration of circulating LDL occurs either as a result of hepatic overproduction of VLDL particles, the major precursors of LDL, or as a result of delayed catabolism, as occurs when there is a deficit of cellular LDL receptors (e.g. familial hypercholesterolemia), or as a combination of both. The major qualitative anomaly of LDL which results in elevated atherogenicity involves a predominance of small dense LDL, as seen in patients with premature coronary heart disease and equally in combined hyperlipidemia and in hypertriglyceridemia. The mechanism of the formation of these particles is complex and involves the concerted intravascular action of cholesteryl ester transfer protein (CETP), lipoprotein lipase (LPL) and hepatic lipase (HL) on triglyceride-rich precursors of dense LDL Lipid-lowering agents, such as fibrates and statins, act to reduce the atherogenicity of dense LDL by distinct mechanisms, which lead to normalisation of circulating LDL levels and/or to targeted reduction in dense particles of elevated atherogenicity. Indeed, such pharmacological probes have facilitated new insight into the molecular and cellular mechanisms which underlie each of the major forms of atherogenic dyslipidemia.
Asunto(s)
Arteriosclerosis/etiología , Lipoproteínas LDL/fisiología , Humanos , Hipercolesterolemia/complicaciones , Lipoproteínas LDL/sangreAsunto(s)
Butiratos/farmacología , Proteínas de Unión al ADN/agonistas , Hipolipemiantes/farmacología , Metabolismo de los Lípidos , Proteínas Nucleares/agonistas , Compuestos de Fenilurea/farmacología , Receptores Citoplasmáticos y Nucleares/agonistas , Factores de Transcripción/agonistas , Dedos de Zinc , Animales , Fenofibrato/farmacología , Humanos , Masculino , Ratones , Ratas , Ratas Sprague-DawleyRESUMEN
A positive exercise electrocardiogram (ECG) is not infrequent occurrence in asymptomatic hypercholesterolemic patients, but the number of false-positive tests may be relatively high (50%). Therefore, the ability of a positive stress ECG to predict coronary artery lesions is low even in populations with > or =1 cardiovascular risk factors. To increase the diagnostic value of exercise tests for screening asymptomatic individuals, we analyzed whether combined clinical parameters with carotid echography would accurately predict coronary atherosclerotic lesions by coronary angiography in asymptomatic hypercholesterolemic patients with a positive exercise ECG. Seventy-six asymptomatic patients (between 35 and 65 years of age) with hypercholesterolemia (total plasma cholesterol >6.5 mmol/L or 250 mg/dl) and a positive stress ECG were referred for carotid B-mode echography and coronary angiography. Carotid echography data were divided into 2 categories: (1) absence of any atherosclerotic plaque, or (2) presence of > or =1 arterial plaques. Coronary stenosis assessed by coronary angiography was considered to correspond to a > or =50% reduction of coronary lumen diameter. Forty-three patients (57%) displayed coronary lesions; most (38; 88%) had carotid plaque. Multivariate analysis showed that the presence of carotid plaque was significantly associated with coronary stenosis (odds ratio 15.2; confidence interval 5.0 to 54.5). In subgroups characterized by high frequency of false-positive exercise electrocardiographic tests (women and patients with a 10-year predicted risk of coronary artery disease [CAD] <15%), none of the patients without carotid plaque exhibited coronary lesions. Echographic evaluation of carotid plaque (plaque vs no plaque) significantly improved the diagnostic specificity of exercise electrocardiography. We conclude that the combination of clinical, electrical, and echographic data facilitates cost-effective noninvasive detection of CAD in asymptomatic hypercholesterolemic patients.
Asunto(s)
Estenosis Carotídea/diagnóstico por imagen , Enfermedad de la Arteria Coronaria/epidemiología , Hipercolesterolemia/complicaciones , Arterias Carótidas/diagnóstico por imagen , Estenosis Carotídea/complicaciones , Angiografía Coronaria , Enfermedad de la Arteria Coronaria/complicaciones , Enfermedad de la Arteria Coronaria/diagnóstico , Electrocardiografía , Prueba de Esfuerzo , Femenino , Humanos , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Medición de Riesgo , UltrasonografíaRESUMEN
A novel gene encoding a protein containing Sm motif-like domains was found to have elevated expression in pancreatic cancer and in several cancer-derived cell lines. CaSm (for Cancer-associated Sm-like) mRNA is up-regulated in 87.5% (seven of eight) of pancreatic tumor/normal pairs. Similarly, cell lines from cancers originating in liver, ovary, lung, and kidney show increased CaSm expression compared to their normal tissue cognates. CaSm encodes a 133-amino acid open reading frame that contains the two Sm motifs found in the common snRNP proteins, with the greatest homology to the Sm G protein (60% similarity). Two hypothetical proteins from Caenorhabditis elegans and Saccharomyces cerevisiae share even greater similarity (72.8 and 67.7%, respectively), suggesting a broad family of proteins containing Sm motifs. Antisense CaSm RNA is able to alter the transformed phenotype of pancreatic cancer cells by reducing their ability to form large colonies in soft agar when compared to untransfected cells. Therefore, CaSm expression appears to be necessary for maintenance of the transformed state.
Asunto(s)
Autoantígenos/análisis , Transformación Celular Neoplásica , Proteínas de Neoplasias/análisis , Neoplasias Pancreáticas/química , Ribonucleoproteínas Nucleares Pequeñas , Secuencia de Aminoácidos , Autoantígenos/genética , Autoantígenos/fisiología , Humanos , Datos de Secuencia Molecular , Neoplasias Pancreáticas/patología , ARN Mensajero/análisis , Regulación hacia Arriba , Proteínas Nucleares snRNPRESUMEN
The hypocholesterolemic activity for novel ureido fibrate analogues was found to be over 100-fold greater than for any "second-generation" fibrate in cholesterol-fed rats. A comparison of 12 related analogues revealed that the optimal configuration for a urea-bridging region located between two aromatic rings consisted of a trisubstituted nitrogen, optimally substituted with a C7 alkyl chain and linked by dimethylene to a phenoxyisobutyrate moiety found in most fibrate analogues. The hypocholesterolemic potency of these compounds was found to correlate with their increased intrinsic fibrate activity as determined by the ability to induce omega-hydroxylase activity either in rat hepatocyte cultures or in vivo, and not with their 10-fold increased ACAT inhibitory potency when compared to other fibrates. The most active compound, 2-(4-(2-(N'-(2,4- difluorophenyl)-N-heptylureido)ethyl)phenoxy)-2-methylpropionic acid, referred to as (2), was found to induce omega-hydroxylase activity in hepatocytes at concentrations between 5 and 100 nM compared to 1-20 microM concentrations for bezafibrate, and lower serum VLDL+LDL cholesterol in rats at doses between 0.1 and 0.5 mg/kg per day compared to doses of 25-100 mg/kg per day for bezafibrate. Single-dose pharmacokinetic studies with 2 indicated that total drug exposure will be much lower at hypocholesterolemic doses due to the enhanced intrinsic activity, and may result in an improved safety profile for these novel trisubstituted ureido fibrate analogues in rats and humans compared to other fibrates.
Asunto(s)
Bezafibrato/química , Bezafibrato/farmacología , Hipolipemiantes/química , Hipolipemiantes/farmacología , Esterol O-Aciltransferasa/antagonistas & inhibidores , Animales , Bezafibrato/farmacocinética , Butiratos/química , Butiratos/farmacología , Células Cultivadas , Relación Dosis-Respuesta a Droga , Humanos , Hipolipemiantes/farmacocinética , Hígado/citología , Hígado/enzimología , Hígado/metabolismo , Masculino , Concentración Osmolar , Compuestos de Fenilurea/química , Compuestos de Fenilurea/farmacología , Ratas , Ratas Sprague-Dawley , Esterol O-Aciltransferasa/metabolismo , Relación Estructura-ActividadRESUMEN
Single crystals of human plasma low density lipoprotein (LDL), the major transport vehicle for cholesterol in blood, have been produced with a view to analysis of the three-dimensional structure by x-ray crystallography. Crystals with dimensions of approximately 200 x 100 x 50 microm have been reproducibly obtained from highly homogeneous LDL particle subspecies, isolated in the density ranges d = 1.0271-1. 0297 g/ml and d = 1.0297-1.0327 g/ml. Electron microscopic imaging of ultrathin-sectioned preparations of the crystals confirmed the existence of a regular, quasihexagonal arrangement of spherical particles of approximately 18 nm in diameter, thereby resembling the dimensions characteristic of LDL after dehydration and fixation. X-ray diffraction with synchrotron radiation under cryogenic conditions revealed the presence of well resolved diffraction spots, to a resolution of about 29 A. The diffraction patterns are indexed in terms of a triclinic lattice with unit cell dimensions of a = 16. 1 nm, b = 39.0 nm, c = 43.9 nm; alpha = 96.2 degrees, beta = 92.1 degrees, gamma = 102 degrees, and with space group P1.
Asunto(s)
Lipoproteínas LDL/química , Cristalografía por Rayos X , Humanos , Lipoproteínas LDL/sangre , Microscopía Electrónica , Conformación ProteicaRESUMEN
The semicarbazones, thiosemicarbazones and acetyl-hydrazones of phthalimide, o-benzosulfimide, naphthalimide and diphenimide demonstrated potent cytotoxicity against murine and human leukemia cell growth and cultured cell growth from human solid tumors. The major site of inhibition in L1210 leukemia cells was DNA synthesis after 60 min incubated with the agents at 25, 50 and 100 microM. De novo synthesis of purines at the regulatory enzyme sites of PRPP amidotransferase and IMP dehydrogenase were the major targets of the agent. Thymidylate synthetase, dihydrofolate reductase and ribonucleoside reductase activities were inhibited by the agents in a manner which would contribute to the overall reduction of DNA synthesis and cell death. d(NTP) pools were significantly reduced and the evidence suggests that the agents interacted with DNA affording DNA strand scission which would interfere with both template utilization by the polymerases and also ultimately reduce nucleic acid synthesis.
Asunto(s)
Antineoplásicos/farmacología , Hidrazonas/farmacología , Imidas/farmacología , Leucemia L1210/tratamiento farmacológico , Semicarbazonas/farmacología , Tiosemicarbazonas/farmacología , Amidofosforribosiltransferasa/antagonistas & inhibidores , Animales , Replicación del ADN/efectos de los fármacos , ADN de Neoplasias/biosíntesis , Diseño de Fármacos , Antagonistas del Ácido Fólico , Humanos , IMP Deshidrogenasa/antagonistas & inhibidores , Leucemia L1210/patología , Ratones , Proteínas de Neoplasias/antagonistas & inhibidores , Relación Estructura-Actividad , Timidilato Sintasa/antagonistas & inhibidores , Células Tumorales Cultivadas/efectos de los fármacosRESUMEN
Cyclic imides such as N-substituted alkyl ethers, thioethers, sulfoxides, sulfones and related derivatives were potent agents against human single cell tumors and selected solid tumor growths, eg adenocarcinoma of the colon and glioma. These agents in the L1210 lymphoid leukemia tumor model preferentially inhibited DNA synthesis. The regulatory enzyme sites in the purine pathway were targets of the agents. Other sites of inhibition were DNA polymerase alpha and thymidylate synthetase activities. d(NTP) pool levels were also reduced by the agents over 60 min.
Asunto(s)
Antineoplásicos/farmacología , Imidas/farmacología , Animales , Supervivencia Celular/efectos de los fármacos , Daño del ADN , ADN de Neoplasias/biosíntesis , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Leucemia L1210/tratamiento farmacológico , Leucemia L1210/enzimología , Leucemia L1210/metabolismo , Ratones , Células Tumorales CultivadasRESUMEN
Molecular assembly of plasminogen and tissue-type plasminogen activator (t-PA) at the surface of fibrin results in the generation of fibrin-bound plasmin and thereby in the dissolution of a clot. This mechanism is triggered by specific interactions of intra-chain surface lysine residues in fibrin with the kringle domains of plasminogen, and is further amplified via the interaction of plasminogen kringles with the carboxy-terminal lysine residues of fibrin that are exposed by plasmin cleavage. By virtue of its marked homology with plasminogen, apo(a), the specific apolipoprotein component of Lp(a), may bind to the lysine sites available for plasminogen on the surface of fibrin and thereby interfere with the fibrinolytic process. A sensitive solid-phase fibrin system, which allows the study of plasminogen activation at the plasma fibrin interface and makes feasible the analysis of products bound to fibrin, has been used to investigate the effects of Lp(a) on the binding of plasminogen and its activation by fibrin-bound t-PA. Plasma samples from human subjects with high levels of Lp(a) were studied. We have established that Lp(a) binds to the fibrin surface and thereby competes with plasminogen (Ki = 44 nM) so as to inhibit its activation. We have further shown that Lp(a) blocks specifically carboxy-terminal lysine residues on the surface of fibrin. To further explore the role of apo(a) on the Lp(a) fibrin interactions, we have performed ligand-binding studies using a recombinant form of apo(a) that contains 17 kringle 4-like units. We have shown that recombinant apo(a) binds specifically to fibrin (Kd = 26 +/- 8 nM, Bmax = 26 +/- 2 fmol/well) and that this binding increases upon treatment of the fibrin surface with plasmin (Kd = 8 +/- 4 nM, Bmax = 115 +/- 14 fmol/well). Altogether, our results indicate clearly that binding of native Lp(a) through this mechanism may impair clot lysis and may favor the accumulation of cholesterol in thrombi at sites of vascular injury.
Asunto(s)
Fibrina/metabolismo , Lipoproteína(a)/metabolismo , Plasminógeno/metabolismo , Activador de Tejido Plasminógeno/metabolismo , Apolipoproteínas/metabolismo , Apoproteína(a) , Arteriosclerosis/etiología , Unión Competitiva , Fibrinólisis/fisiología , Humanos , Técnicas In Vitro , Cinética , Kringles/fisiología , Fragmentos de Péptidos/metabolismo , Unión Proteica , Proteínas Recombinantes/metabolismo , Trombosis/etiologíaRESUMEN
A series of novel dermal penetration enhancers, esters and amides of clofibric acid, was synthesized. The permeation parameters and skin retention of two steroids (hydrocortisone-21-acetate and betamethasone-17-valerate) in propylene glycol were studied with athymic nude mouse skin by in vitro diffusion cell techniques in the presence of the novel enhancer compounds. Isopropyl myristate, dimethyl lauramide, and 1-dodecylazacycloheptan-2-one (laurocapram, Azone) were used as control enhancers. The most satisfactory enhancement of both the ester and amide series was observed with clofibric acid octyl amide; coadministration increased skin retention of hydrocortisone acetate after 24 h by 3.5-fold and that of betamethasone valerate by 2.9-fold. Diffusion cell receptor concentrations increased 51.6- and 10.3-fold, respectively, during the same time period. However, the enhancer compound in this case was applied to the skin 1 h prior to each of the steroids. The amide analogues were more effective than the equivalent ester compounds of the same carbon chain length. The best enhancer compounds (2c, 3d, 3e, and 3f) were nonirritating to athymic mouse skin in vivo.